Publication | Open Access

Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas

Endocrine OncologyDacarbazine TreatmentMedicineMetronomic TherapyPharmacologyUnresectable Malignant Pheochromocytomas/paragangliomasPathologyTumor ProgressionPharmacotherapyCancer TreatmentOncologyGliomaTumor Biology